CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Histone Deacetylase as a Valuable Predictive Biomarker and Therapeutic Target in Immunotherapy for Non-Small Cell Lung Cancer
Hyun-Seock Shin, Juwhan Choi, Jinhwan Lee, Sung Yong Lee
Cancer Research and Treatment. 2022;54(2):458-468.   Published online 2021 September 10    DOI: https://doi.org/10.4143/crt.2021.425

Excel Download

Histone Deacetylase as a Valuable Predictive Biomarker and Therapeutic Target in Immunotherapy for Non-Small Cell Lung Cancer
Cancer Research and Treatment. 2022;54(2):458-468   Crossref logo
Link1 Link2 Link3

DNA damage response signaling as a predictive biomarker and synergistic therapeutic target for anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer
Thoracic Cancer. 2018;9(8):901-903   Crossref logo
Link1 Link2

Phase II trial of the histone deacetylase inhibitor pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancer
Lung Cancer. 2004;   Crossref logo
Link1 Link2

Histone Deacetylase Inhibitors in Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology. 2012;7(12):S404-S406   Crossref logo
Link1 Link2

Epiregulin as a therapeutic target in non-small-cell lung cancer
Lung Cancer: Targets and Therapy. 2015;91   Crossref logo
Link1

Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?
Frontiers in Cell and Developmental Biology. 2020;8:   Crossref logo
Link1

244 Antitumor effects of a novel histone deacetylase inhibitor (chidamide) on non-small cell lung cancer cell lines
European Journal of Cancer. 2015;51:S41   Crossref logo
Link1 Link2

Combined histone deacetylase and NF-κB inhibition sensitizes non-small cell lung cancer to cell death
Surgery. 2004;136(2):416-425   Crossref logo
Link1 Link2

GCC2 is a New Biomarker for Diagnosis of Early Non-Small Cell Lung Cancer and A Potential Target to Reverse Epithelial to Mesenchymal Transition
. 2021;   Crossref logo
Link1 Link2

EGFR T790M mutation as a novel target for immunotherapy against EGFR-TKI-resistant non-small cell lung cancer
Journal for ImmunoTherapy of Cancer. 2013;1(S1):   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.